// App-Quantinova.ai

525 : Recovery of Renal Function Among ANCA-Associated Vasculitis Patients with Baseline eGFR ≤20 in the Avacopan ADVOCATE Trial

Researchers

Presenter

  • David Jayne

Principal Investigators

  • Peter Merkel

  • Frank Cortazar

  • John Niles

  • Pirow Bekker

Medical Centers

  • University of Cambridge, Cambridge, United Kingdom

  • University of Pennsylvania, Philadelphia, PA

  • St. Peter's Hospital, Albany, NY

  • Harvard, Boston, MA

  • ChemoCentryx, San Juan Capistrano, CA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

  • Genetic Disorder

Disease

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

  • Renal disease

Biomarkers

  • Creatinine

Drug/Treatment

  • CCX-168

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved